Welldoc is a digital health company that offers an AI-driven platform focused on cardiometabolic health. It delivers personalized, actionable insights to individuals and care teams to improve diabetes and related conditions, while enabling population health management and clinical decision support for healthcare organizations. The platform integrates data from hundreds of devices and solutions, supports care workflows, and includes FDA-cleared diabetes products for clinical use. Headquartered and operating in the United States, Welldoc collaborates with health plans, health systems, and employers to scale chronic care management.
No recent news for this company.
No recent deals for this company.